Ryan White 2012 Grantee Meeting

While the National HIV/AIDS Strategy (NHAS) is an unprecedented effort to reduce and control the HIV epidemic, one crucial implication is its impact on those co-infected with HIV and viral hepatitis; one of the leading causes of death among those co-infected. An estimated 25 percent of HIV-positive persons are co-infected with hepatitis C and approximately 10 percent are co-infected with hepatitis B. The release of the Health and Human Services Viral Hepatitis Action Plan is also an unprecedented effort to reduce and control viral hepatitis. While access to viral hepatitis care and treatment may be challenging for some who are co-infected, there are opportunities and strategies that should be considered to obtain positive health outcomes.

Learning Objectives:

• Participants will describe the disease burden of both mono- and co-infection of viral hepatitis and HIV.
• Participants will describe the challenges of obtaining and providing viral hepatitis services in the United States.
• Participants will understand the viral hepatitis public heath landscape including current recommendations by key federal agencies for providers.